Introduction {#s1}
============

Formation of the eyelid is one of the last major morphogenetic events in mammalian prenatal development. Though for the most part data are scarce in humans, histological analyses of available embryos/fetuses have shown that eyelid development proceeds through four distinct phases, namely, lid formation, growth, fusion and re-opening [@pone.0087038-Pearson1], [@pone.0087038-Byun1]. In mice, eyelid development follows similar steps but has been characterized in greater detail. Mouse eyelid formation begins at around embryonic day 11.5 (E11.5). At this time, the surface ectoderm adjacent to the developing cornea folds to form the lid buds, which are a simple structure consisting of loose periocular mesenchyme (POM) covered by undifferentiated ectoderm [@pone.0087038-Harris1]--[@pone.0087038-Tao1]. The eyelid buds grow from E12 onward, and they extend across the ocular surface, undergoing proliferation and differentiation. The eyelid at this stage is covered by epidermis, overlaid by periderm at the anterior surface and conjunctiva at the posterior surface. The epithelial margins of the superior and inferior lid fuse between E15 - E16. Lid fusion begins when the periderm cells become rounded and piled up at the leading edges of the eyelids, and then stream out across the corneal surface. The eyelids meet at the inner and outer canthi and temporarily fuse across the cornea [@pone.0087038-Harris1], [@pone.0087038-Findlater1]. Once contact is established between the apposed eyelids, the cells at the fusion junction flatten and form a strip along the fusion line, and they slough off with the rest of the periderm [@pone.0087038-Findlater1], [@pone.0087038-Harris2], [@pone.0087038-Juriloff1]. Mouse eyelid remains closed between E16.5 and postnatal day 12--14. Cells at the eyelid fusion junction undergo desquamation and/or apoptosis, resulting in separation of the upper and lower eyelids at around postnatal day 14 [@pone.0087038-Findlater1], [@pone.0087038-Mohamed1].

Much is known about the molecular factors involved in eyelid formation and fusion. This is because, although mice are normally born with a closed eyelid, a large number of genetic mutant strains display a distinct "eye open at birth" (EOB) phenotype. The Mouse Genome Informatics (MGI) (<http://www.informatics.jax.org/>) has a collection of \>138 genotypes associated with the phenotype; the number is likely to increase with complete or partial knockout of new genes.

The majority of the EOB phenotype is caused by failure of eyelid fusion at E15--E16. One of the most significant findings made by the analysis of EOB mice is that multiple signaling pathways are involved in the regulation of eyelid closure. Some pathways, such as RA-RXR/RAR and PITX2-DKK2, and the FOXL and OAR2 transcription factors, seem to operate in the periocular mesenchyme [@pone.0087038-Matt1]--[@pone.0087038-Gage1]; others, such as the FGF10-FGFR and BMP-BMPR pathways, act through crosstalk between mesenchyme and epithelium [@pone.0087038-Tao1], [@pone.0087038-Huang1]. Furthermore, a number of pathways, including MAP3K1-JNK, EGFR, ROCK and PCP, are specifically effective in the eyelid epithelial cells [@pone.0087038-Schaeper1]--[@pone.0087038-Torban1]. There is also evidence for signal compartmentalization and spatial segregation, so that the signaling pathways are activated in distinct cell population in the developing eyelids [@pone.0087038-Takatori1], [@pone.0087038-Wu1].

Though the outline of the pathways is more or less drawn, the role that the actual players involved in signal transduction has not been fully understood. Genetic knockout studies in mice have helped to elucidate the roles of some of the signaling molecules. Using this approach, it is shown that multiple EGFR ligands act additively to regulate eyelid morphogenesis. Thus, whereas the *Hb-egf*-null and *Tgfα*-null mice display occasionally "open-eye" phenotype, the compound mutants, i.e. *Hb-egf(−/−)Tgfα(+/−)* and *Hb-egf(+/−)Tgfα(−/−)*, have a slightly increased penetrance, and the double homozygous null mice have a drastically increased penetrance of the phenotype. Furthermore, the triple null mice, lacking three of the EGFR ligand genes, *Egf*, *Areg* and *Tgfα*, exhibit a severe "eye-open" phenotype [@pone.0087038-Luetteke1]. Similarly, by generating a series of genetic mutant strains, Huang, *et. al*. have shown the BMP signaling is specifically involved in eyelid closure. Mice lacking components of the TGFβ pathways have normal eyelid development, but those with impaired BMP signaling display an 'eyelid open at birth' phenotype [@pone.0087038-Huang1].

The most remarkable feature of lid closure is the shape change and migration underwent by the epithelial cells at the "tip" of the eyelid. This is accompanied by activation of specific morphogenetic pathways. It is possible that the tip cells have unique surrounding tissues, i.e., microenvironments, which produce morphogens for specific activation of signaling pathways. Alternatively, the tip cells may have unique gene expression thereby acquiring new signaling and morphogenetic properties. Gene expression is a crucial facet of its function, and many genes essential for eyelid closure, such as *Tgfα*, *Hb-egf*, *Activinβb* and *Map3k1*, are indeed up-regulated in the developing eyelid epithelium [@pone.0087038-Tao1], [@pone.0087038-Zhang1], [@pone.0087038-Luetteke2], [@pone.0087038-Vassalli1].

In the present work, we applied a global approach to compare gene expression profiles in epithelial cells isolated from the tip (leading edge, LE) and the inner surface (inner epithelium, IE) of the embryonic eyelid. We evaluated the relative abundance in expression of genes whose products might constitute the major "eyelid closure pathways". Results may help to understand how signals are distinctly regulated in the LE cells and provide guidance for selecting "genes of interest" for expression and knockout studies.

Materials and Methods {#s2}
=====================

Experimental animals {#s2a}
--------------------

C57BL/6 fetuses were collected at E15.5. Euthanasia of the E15.5 fetuses was done by decapitation with surgical scissors, and genotypes were determined by PCR. Experiments conducted with these animals were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Cincinnati (Protocol no. 06-04-19-01).

Tissue and cell preparation, RNA and cDNA generation and microarray {#s2b}
-------------------------------------------------------------------

This process was done as previously described [@pone.0087038-Jin1]. Briefly, the heads of E15.5 fetuses were embedded in Tissue-Tek OCT medium (Sakura Finetek USA) and stored in −80°C. Eight µm coronal sections were mounted on plain uncoated glass slides, dehydrated and stained with HistoGene LCM frozen section staining kit, and were used for LCM following the manufacturer\'s protocol (Molecular Devices). Cells from 4 sections were collected on one LCM cap and lysed for RNA harvesting. The lysates from each fetus were pooled and processed as one biological sample. It was estimated that 10 ng and 15 ng total RNA were obtained from LE and IE eyelid epithelium, respectively, per fetus.

RNA was analyzed by Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) and samples with RNA Integrity Number (RIN) \>5.5 were processed for cDNA amplification. cDNA amplification and biotinylation was done using Ovation Pico WTA System (NuGEN, San Carlos, CA) following the manufacturer\'s instructions. Specifically, RNA (10 ng) was processed into first strand cDNA, a DNA/RNA heteroduplex, and thereafter a linear isothermal amplified cDNA. The amplified cDNA was purified with a PCR Purification Kit (QIAGEN, Valencia, CA).

The cDNAs from each fetus were considered one biological sample and 3 samples were used for triplicate hybridization on the Affymetrix GeneChip Mouse Gene 1.0 ST array (P/N 901168, Affymetrix, Santa Clara, CA). The arrays were hybridized with 15 µg of fragmented aRNA. The hybridization, staining, and washing are carried out using the Affymetrix GeneChip Hybridization Wash and Stain Kit (P/N 900720) following the manufacturer\'s protocols. The arrays were hybridized for 16 hr at 45°C using Affymetrix Hybridization Oven 640 (P/N 800139). FS450-0001 protocol was used for staining and washing the GeneChips using the Affymetrix Fluidics Station 450 (P/N 00-0079). The GeneChips were scanned with Affymetrix GeneChip Scanner 3000 7G Plus using Affymetrix GeneChip Command Console 3.2.3.1515 software and Affymetrix preset settings.

Quantitative RT-PCR {#s2c}
-------------------

Quantitative PCR was performed using an MX3000p thermal cycler system and SYBR Green QPCR Master Mix (Stratagene), using conditions optimized for each target gene primers with efficiency greater than 85%, cycles less than 29 and sample locations on the plates been randomized. The PCR products were subjected to melting curve analysis and the relative cycle differences in qRT-PCR were determined using ΔCt, as described [@pone.0087038-Schnekenburger1]. The ΔCt value for each sample was determined using the cycle threshold (Ct) value of the specific gene normalized to that of *Gapdh*. The fold change was calculated based on the ratio between LE versus IE (control) samples, designated as 1. Data are based on triplicate reactions of at least 3 biological samples.

Statistical and bioinformatics analyses {#s2d}
---------------------------------------

Array data (GEO repository, accession no. GSE39240) were analyzed at gene level using statistical software R and the limma package of Bioconductor [@pone.0087038-Smyth1] with custom CDF downloaded from BrainArray [@pone.0087038-Dai1]. Data pre-processing, including background correction and normalization, was performed using RMA. Array quality was assessed using the Array Quality Metrics package of Bioconductor [@pone.0087038-Kauffmann1]. Statistical significance of differential gene expression between LE and IE samples were established based on empirical Bayes linear model as implemented in limma package [@pone.0087038-Smyth1].

Functional enrichment analysis of differentially expressed genes was performed using the logistic regression based LRpath methodology [@pone.0087038-Sartor1] as implemented in the R package CLEAN [@pone.0087038-Freudenberg1]. The gene list used in the functional enrichment analysis came from genes associated with Gene Ontology terms [@pone.0087038-Ashburner1]. The statistical significance of gene list enrichment was determined based on the False Discovery Rate (fdr) cut-off of 0.1. The statistical significance of deviations of average gene expression levels for genes within the same group were established by calculating gene specific z-statistics and comparing it to the standard Normal distribution. The z-statistic was calculated by subtracting the average of expression levels of all genes in the group from the expression level of the gene and dividing the difference by the standard deviation of the expression levels within the group.

Results and Discussion {#s3}
======================

Gene expression profiles in the developing eyelid epithelium {#s3a}
------------------------------------------------------------

To identify the molecular signatures of eyelid closure, we collected mouse fetuses at E15.5, a developmental stage immediately before the eyelid beginning to close. We used laser capture microdissection (LCM) to isolate epithelial cells from the leading edge (LE) and inner surface epithelium (IE). The samples were used for expression array and gene expression signatures were analyzed as described [@pone.0087038-Jin1].

To determine whether the LE and IE cells were different at E15.5, we analyzed the expression data by Gene Ontology (GO). The LE cells were enriched for genes involved in epidermis development, transcription factor activity, pattern specification and odontogenesis. By contrast, the IE cells were enriched for genes for muscle development, RNA splicing, microtubule organization and centrosomes ([Table 1](#pone-0087038-t001){ref-type="table"}). The GO signatures suggest that the E15.5 LE and IE cells have already departed to distinct paths from their common origin - the ocular surface ectoderm.

10.1371/journal.pone.0087038.t001

###### Gene Functions in LE and IE Cells.

![](pone.0087038.t001){#pone-0087038-t001-1}

  categoryID                                         description                       nGenes     zScore        pValue          FDR
  ------------------------------ ---------------------------------------------------- -------- ------------- ------------- -------------
  **Up-regulated in LE cells**                                                                                             
  GO:0008544                                    epidermis development                   202     9.513937667    9.18E-22      4.91E-18
  GO:0001071                      nucleic acid binding transcription factor activity    725     7.756885322    4.35E-15      7.76E-12
  GO:0007389                                pattern specification process               389     6.372488177    9.30E-11      6.78E-08
  GO:0042475                           odontogenesis of dentin-containing tooth          56     6.359209662    1.01E-10      6.78E-08
  **Up-regulated in IE cells**                                                                                             
  GO:0005865                                striated muscle thin filament                15     9.710632193   1.35823E-22   7.26656E-19
  GO:0008380                                         RNA splicing                       222     7.022839172   1.08702E-12   2.90778E-09
  GO:0005815                                microtubule organizing center               353     5.980688777   1.11098E-09   8.49106E-07
  GO:0005813                                          centrosome                        334     5.947685008   1.35981E-09   9.09371E-07

Expression of signaling molecules in the FGF and EGF pathways {#s3b}
-------------------------------------------------------------

To evaluate whether the LE and IE cells had differential expression of signaling molecules, we examined genes involved in the FGF and EGF pathways, known to be involved in eyelid closure. The fibroblast growth factor (FGF) family has 22 ligands and four membrane-bound receptors, FGFR 1-4, with different ligand binding affinities [@pone.0087038-Reuss1], [@pone.0087038-Goetz1]. In LE and IE cells, the *Fgfr2* was the most abundantly expressed receptor gene, and *Fgf9* was the highly expressed ligand gene ([Table 2](#pone-0087038-t002){ref-type="table"}). Between LE and IE, there was no major difference in the expression of genes belonging to the families of FGF ligands and receptors, except for *Fgfr2* ([Table 2](#pone-0087038-t002){ref-type="table"}). The level of *Fgfr2* was 1.8-fold higher in LE cells, suggesting that the LE cells might be more responsive to FGF signals than the IE cells.

10.1371/journal.pone.0087038.t002

###### Expression of Genes in the FGF pathways

![](pone.0087038.t002){#pone-0087038-t002-2}

                                     LE                          IE               LE/IE                                                             
  ----------------- ------------------------------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------
  ***Ligands***                                                                                                                                     
  *Fgf9*                 fibroblast growth factor 9        **391.7362245**   **0.002337928**   **390.6433611**   **0.019267398**     1.002797599      0.240347549
  *Fgf8*                 fibroblast growth factor 8          166.5464506       0.155681338       168.861405        0.535466303      -1.013899752       0.2104111
  *Fgf22*                fibroblast growth factor 22         126.5957788       0.368634212       159.4079042       0.616024893      -1.259188147      0.291215529
  *Fgf17*                fibroblast growth factor 17         125.059223        0.381111278       120.5839736       0.943298623       1.037113136      0.142005947
  *Fgf15*                fibroblast growth factor 15         106.552639        0.567451803       196.9766114       0.349464154      -1.848631936      0.423612008
  *Fgf18*                fibroblast growth factor 18         100.7913239       0.641017588        210.65336        0.283116505       -2.08999497      0.519448518
  *Fgf13*                fibroblast growth factor 13         89.66438499       0.807082058       189.7867092       0.390149852       -2.11663426      0.303068764
  *Fgf23*                fibroblast growth factor 23         87.28123282       0.846919936       129.6743787       0.937844546       -1.48570746      0.083917121
  *Fgf12*                fibroblast growth factor 12         85.02659868       0.886003145       165.5686431       0.562397439      -1.947257043      0.183738989
  *Fgf14*                fibroblast growth factor 14         81.91780637       0.942085876       151.3383997       0.692901632      -1.847442045      0.860187995
  *Fgf4*                 fibroblast growth factor 4          77.78685355       0.979586236       99.0757551        0.635380846      -1.273682513      0.229425806
  *Fgf2*                 fibroblast growth factor 2          70.66744472       0.835369348       217.5071721       0.254690818      -3.077897793       0.13672465
  *Fgf3*                 fibroblast growth factor 3          68.74815066       0.794789854       90.72130986       0.512539018      -1.319618186      0.335560338
  *Fgf11*                fibroblast growth factor 11         68.56522928       0.790890829       75.35099222       0.300332225       -1.09896799      0.170136214
  *Fgf20*                fibroblast growth factor 20         66.76075364       0.752163879       108.3953639       0.772018719      -1.623639009      0.832224495
  *Fgf5*                 fibroblast growth factor 5          56.66072417       0.53052365        83.88846438       0.414768503      -1.480539926      0.545076451
  *Fgf6*                 fibroblast growth factor 6          56.09740044       0.518165165       61.21500656       0.14375436       -1.091227153      0.004820016
  *Fgf1*                 fibroblast growth factor 1          50.52878074       0.39830177        66.54665181       0.196832397       -1.3170049       0.871058322
  *Fgf16*                fibroblast growth factor 16         46.44946676       0.315151851       83.9707348        0.415920032      -1.807786842      0.213019604
  *Fgf21*                fibroblast growth factor 21         43.45787888       0.258114299       80.28778119       0.365183695      -1.847485042       0.47884619
  *Fgf7*                 fibroblast growth factor 7          40.01974398       0.197978384       177.3818719       0.47111134       -4.432358986      0.137301471
  *Fgf10*                fibroblast growth factor 10         39.45348786       0.188715937       62.20935837       0.153034151      -1.576777156           NA
  ***Receptors***                                                                                                                                   
  *Fgfr2*            fibroblast growth factor receptor 2     813.1860577       0.193619621       451.5885556       0.235326753     **1.800723352**   **0.01626331**
  *Fgfr1*            fibroblast growth factor receptor 1     300.4716334       0.813353765       255.3859332       0.794570092       1.176539482      0.179540765
  *Fgfr3*            fibroblast growth factor receptor 3     140.6777924       0.565431926       188.2482391       0.813949118      -1.338151785           1
  *Fgfr4*            fibroblast growth factor receptor 4     97.98335351       0.336423871       103.2283889       0.225590878      -1.053529862      0.145817534

Previously, we have shown that FGF9 expression was decreased in LE cells of *Map3k1* knockout fetuses corresponding to failure of eyelid closure [@pone.0087038-Jin1]. FGF9 could act in an autocrine fashion to induce epithelial branching, or it could send signals to the mesenchyme to induce PITX2 and FGF10. FGF10 in turn could trans-activate FGFR in epithelial cells and stimulate epithelial budding [@pone.0087038-Al1], [@pone.0087038-Okada1]. Genetic studies show that FGF10 is crucial for eyelid closure, but FGF9, though required for sex determination and reproductive system development, lung embryogenesis, and inner ear morphogenesis, is dispensable for eyelid development [@pone.0087038-Colvin1]--[@pone.0087038-Pirvola1]. Since FGF10 was almost undetectable in LE and IE cells, it is possible that this ligand is produced by the underlying mesenchymal cells, responsible for activation of FGFR2 in the eyelid epithelium [@pone.0087038-Li1], [@pone.0087038-Tao1].

The epidermal growth factor (EGF) pathway operates in an autocrine fashion, such that ligands produced by the epithelial cells can activate receptors on the same or nearby cells [@pone.0087038-Tao1], [@pone.0087038-Luetteke2], [@pone.0087038-Zenz1], [@pone.0087038-Li2]. The mammalian system has nine ligands, which are first expressed as transmembrane proteins comprising a signal sequence, a transmembrane domain and the EGF domain(s). The ligands are then activated by ectodomain shedding that releases the EGF domain from the membrane-bound precursors. This is carried out by members of disintegrin and metalloproteases (ADAMS) family of type I transmembrane Zn-dependent proteases. There are four EGF receptor tyrosine kinases, including EGFR/ERBB1, ERBB2, ERBB3 and ERBB4 [@pone.0087038-Hynes1]. Activation of the receptors is also facilitated by members of the leucine-rich repeat containing G-protein coupled receptor (LGR) and G protein-coupled receptor (GPCR) families.

In LE and IE cells, the *Egfr* and *Erbb2*, and several genes in the GPCR families, such as *Lgr4*, *Gpr125*, *Gpr20, Gpr180*, *Gpr89* and *Gpr3*, were abundantly expressed ([Tables 3](#pone-0087038-t003){ref-type="table"} and [4](#pone-0087038-t004){ref-type="table"}). Expression of *Adams10* was also abundant ([Table 5](#pone-0087038-t005){ref-type="table"}). Expression of *Gpr56* was relatively abundant in LE cells, whereas expression of *Adam 17*, *Lgr4*, *Gpr107* and *Gpr137b-ps* was more abundant in IE cells. Compared to the IE cells, the LE cells had significantly higher expression of *Erbb2* (1.8-fold) and *Gpr56* (1.3-fold), but less expression of *Adamts1* (-2.6-fold).

10.1371/journal.pone.0087038.t003

###### Expression of Genes in the EGF pathways

![](pone.0087038.t003){#pone-0087038-t003-3}

  ----------------- ----------------------------------------------------------- ------------- ------------- ------------- ------------- ----------------- -----------------
                                                LE                                   IE           LE/IE                                                   
  symbol                                       name                                ave.int        p-val        ave.int        p-val           fold              p.val
  The EGF family                                                                                                                                          
  ***Ligands***                                                                                                                                           
  *Areg*                                   amphiregulin                          155.3082961   0.133546244   196.8743744   0.233004491    -1.267635917       0.478968664
  *Hbegf*                     heparin-binding EGF-like growth factor             128.9845997   0.297282478   167.4743744   0.384089575    -1.298405971       0.478845479
  *Tgfa*                         transforming growth factor alpha                105.2105058   0.589279991   153.7290675   0.484086582    -1.461157005       0.202676617
  *Nrg1*                                   neuregulin 1                          98.00624272   0.715140496   155.8413258   0.467264689    -1.590116318       0.685383852
  *Btc*                 betacellulin, epidermal growth factor family member      87.55213556   0.930827589   117.8289953   0.865162398    -1.345815205       0.715209746
  *Nrg2*                                   neuregulin 2                          83.82453012   0.983653113    79.467853    0.538534554     1.054823139           NA
  *Nrg3*                                   neuregulin 3                          58.13060811   0.355939687   103.0507744   0.922549334    -1.772745509       0.478847044
  *Ereg*                                    epiregulin                           52.18751712   0.234405883   55.55150234   0.184028108    -1.064459576       0.565380436
  *Egf*                               epidermal growth factor                    47.88076511   0.161070096   48.01846247   0.105485701    -1.002875839       0.478845479
  ***Receptors***                                                                                                                                         
  *Erbb2*            v-erb-b2 erythroblastic leukemia viral oncogene homolog 2   400.0763611   0.357543272   224.2186429   0.920362594   **1.784313543**   **0.018738394**
  *Egfr*                         epidermal growth factor receptor                268.515161    0.647969842   410.0439401   0.18271137     -1.527079285       0.478850402
  *Erbb3*            v-erb-b2 erythroblastic leukemia viral oncogene homolog 3   184.0990756   0.985729198   174.7380987   0.682470129     1.05357147        0.273357054
  *Erbb4*            v-erb-a erythroblastic leukemia viral oncogene homolog 4    54.61474781   0.163158368   129.3400888   0.30614936     -2.368226422       0.472018438
  ----------------- ----------------------------------------------------------- ------------- ------------- ------------- ------------- ----------------- -----------------

10.1371/journal.pone.0087038.t004

###### Expression of genes in the *Lgr* and *Gpr* families

![](pone.0087038.t004){#pone-0087038-t004-4}

                                              LE                                    IE           LE/IE                                                
  -------------- ------------------------------------------------------------- ------------- ------------- ------------- ------------- -------------- -------------
  ***Lgr***                                                                                                                                           
  *Lgr4*          leucine-rich repeat-containing G protein-coupled receptor 4   157.3388508   0.404500028   383.3124767   0.25234085    -2.43622268    0.287853304
  *Lgr6*          leucine-rich repeat-containing G protein-coupled receptor 6   116.419403    0.783191878   103.8732732   0.481567664   1.120783041    0.129157861
  *Lgr5*          leucine rich repeat containing G protein coupled receptor 5   55.18917435   0.267528025   125.0686009   0.659286312   -2.266179959   0.596789619
  ***Gpr***                                                                                                                                           
  *Gpr125*                      G protein-coupled receptor 125                  220.1038045   0.021084389   289.8375491   0.026009754   -1.316822078   0.500824711
  *Gpr56*                        G protein-coupled receptor 56                  218.8178318   0.021853992   171.4743744   0.303240853    1.2760964     0.01999301
  *Gpr20*                        G protein-coupled receptor 20                  211.4585922   0.026852976   316.8945328   0.01511878    -1.498612705   0.839414104
  *Gpr35*                        G protein-coupled receptor 35                  180.0479953   0.065600296   211.299815    0.132169905   -1.173574938   0.746554847
  *Gpr180*                      G protein-coupled receptor 180                  175.9631725   0.073778453   225.2654962   0.098636269   -1.280185467   0.478842536
  *Gpr89*                        G protein-coupled receptor 89                  175.0870638   0.075663315   259.1367522   0.04874379    -1.480045108   0.860737542
  *Gpr3*                         G-protein coupled receptor 3                   166.2545002   0.097617959   256.2424001   0.051748411   -1.541265949   0.33371539
  *Gpr27*                        G protein-coupled receptor 27                  164.4406301   0.102869023   147.2047335   0.495484149   1.117087924    0.000579647
  *Gpr107*                      G protein-coupled receptor 107                  162.419388    0.109055871   229.0743744   0.09108073    -1.410388114   0.137248811
  *Gpr108*                      G protein-coupled receptor 108                  145.2163784   0.17923789    191.0189953   0.202107027   -1.315409442   0.911106857
  *Gpr137*                      G protein-coupled receptor 137                  127.2392185   0.299750484   136.5343716   0.61000012    -1.073052579   0.203778073
  *Gpr135*                      G protein-coupled receptor 135                  124.301855    0.325673932   117.9937349   0.859217628   1.053461483    0.370495905
  *Gpr119*                      G-protein coupled receptor 119                  123.7604085   0.330676321   130.9329503   0.678452003   -1.057955059   0.157171461
  *Gpr75*                        G protein-coupled receptor 75                  123.6542976   0.331665052   135.7166762   0.619626637   -1.097549207   0.216351769
  *Gpr44*                        G protein-coupled receptor 44                  123.3665465   0.334360194   130.317495    0.686333622   -1.056343868   0.496977287
  *Gpr124*                      G protein-coupled receptor 124                  115.0903184   0.42110489    149.9910593   0.468845533   -1.303246541   0.478842349
  *Gpr39*                        G protein-coupled receptor 39                  97.00347273   0.682938697   105.2282022   0.933334644   -1.08478799    0.33371539
  *Gpr123*                      G protein-coupled receptor 123                  96.88645603   0.684992273   125.8634937   0.745514901   -1.29908244    0.247272771
  *Gpr85*                        G protein-coupled receptor 85                  96.61297529   0.689810486   139.7885876   0.572910687   -1.446892481   0.674432534
  *Gpr30*                        G protein-coupled receptor 30                  96.58976307   0.690220652   107.3732646   0.969969091   -1.111642281   0.186297098
  *Gpr153*                      G protein-coupled receptor 153                  94.94188296   0.719823958   98.13033433   0.808122405   -1.033583191   0.312765421
  *Gpr137b-ps*            G protein-coupled receptor 137B, pseudogene           94.78743922   0.722647465   282.2968287   0.030313391   -2.978209255   0.680474406
  *Gpr81*                        G protein-coupled receptor 81                  92.51193082   0.765219363   123.7269258   0.775238854   -1.337415884   0.469995365
  *Gpr4*                         G protein-coupled receptor 4                   92.03372555   0.774396617   103.5068225   0.903492859   -1.124661877   0.85686891
  *Gpr179*                      G protein-coupled receptor 179                  91.13654808   0.791829182   100.0755366   0.842964993   -1.098083466   0.327688347
  *Gpr97*                        G protein-coupled receptor 97                  90.49460245   0.804473656   96.21870568   0.773579498   -1.063253532   0.341054528
  *Gpr172b*                     G protein-coupled receptor 172B                 88.72249257    0.8401129     97.276255    0.792722632   -1.096410303   0.037918301
  *Gpr171*                      G protein-coupled receptor 171                  85.5606136    0.906315064   191.2743744   0.201031884   -2.235542341   0.288166398
  *Gpr25*                        G protein-coupled receptor 25                  84.40014173   0.931423514   98.44886788   0.813850833   -1.166453822   0.065281383
  *Gpr6*                         G protein-coupled receptor 6                   82.59264406   0.971357511   74.27593798   0.380077813   1.111970395    0.815470951
  *Gpr137b*                     G protein-coupled receptor 137B                 81.25127761   0.998384708   107.3979928   0.970387644   -1.321800665   0.713122571
  *Gpr114*                      G protein-coupled receptor 114                  80.90069545   0.990392729   82.19300262   0.517720661   -1.015973993   0.496210735
  *Gpr17*                        G protein-coupled receptor 17                  80.64630589   0.984572436   96.65240053   0.781439379   -1.198472757   0.48758246
  *Gpr173*                      G-protein coupled receptor 173                  80.57298468   0.982891617   102.3705866   0.883595209   -1.270532387   0.865882429
  *Gpr83*                        G protein-coupled receptor 83                  77.34451159   0.907515055   118.4744165   0.851944372   -1.531775352   0.664800049
  *Gpr183*                      G protein-coupled receptor 183                  75.90513232   0.873125838   136.6792593   0.608307331   -1.800658995   0.977344711
  *Gpr133*                      G protein-coupled receptor 133                  73.77656211   0.821530114   92.57027338   0.707052638   -1.254738236   0.310248937
  *Gpr126*                      G protein-coupled receptor 126                  72.44315307   0.788832074   232.0775545   0.085538588   -3.203581631   0.138923358
  *Gpr18*                        G protein-coupled receptor 18                  72.21733384   0.783270351   182.9476886   0.239134407   -2.533293309   0.501943232
  *Gpr84*                        G protein-coupled receptor 84                  72.20812693   0.783043458   86.08696737   0.588271302   -1.192206072   0.224588613
  *Gpr37l1*                  G protein-coupled receptor 37-like 1               72.13222905   0.781172645   98.78720469   0.819925994   -1.369529349   0.431585749
  *Gpr144*                      G protein-coupled receptor 144                  72.06972089   0.779631349   79.31147279   0.466480372   -1.100482586   0.132102738
  *Gpr157*                      G protein-coupled receptor 157                  71.40005822   0.763090782   96.67623462   0.781870956   -1.354007784   0.358178624
  *Gpr156*                      G protein-coupled receptor 156                  70.40086729   0.738326035   68.5804486    0.289316439   1.026544281    0.478847201
  *Gpr146*                      G protein-coupled receptor 146                  69.62364684   0.719006489   53.54305799   0.104400524   1.300330042    0.13090816
  *Gpr160*                      G protein-coupled receptor 160                  69.39114229   0.713219524   74.72537227   0.387587547   -1.076871915   0.337863882
  *Gpr77*                        G protein-coupled receptor 77                  69.38658457   0.713106053   64.65720239   0.232512432   1.073145481    0.246294322
  *Gpr68*                        G protein-coupled receptor 68                  65.98359522   0.628259898   89.82589824   0.656736889   -1.361336828   0.836126668
  *Gpr162*                      G protein-coupled receptor 162                  63.89859714   0.576464248   71.74780097   0.338720298   -1.122838437   0.753129884
  *Gpr132*                      G protein-coupled receptor 132                  61.01745433   0.505773427   65.42941991   0.243272256   -1.072306615   0.770153611
  *Gpr111*                      G protein-coupled receptor 111                  60.35405182   0.489718441   54.49499311   0.113259572   1.107515542    0.379862366
  *Gpr62*                        G protein-coupled receptor 62                  58.81170703   0.45281891    71.99871533   0.342753671   -1.224224206   0.438288689
  *Gpr26*                        G protein-coupled receptor 26                  58.61960404   0.448269774   80.90301094   0.494654237   -1.380135746   0.470158493
  *Gpr15*                        G protein-coupled receptor 15                  57.40978461   0.419890293   57.81324406   0.147347983   -1.007027712   0.153990594
  *Gpr161*                      G protein-coupled receptor 161                  55.91072381   0.385447822   107.498657    0.972090592   -1.922684052   0.512145141
  *Gpr45*                        G protein-coupled receptor 45                  55.40839734   0.374105939   53.82411607   0.106973001   1.029434413    0.140431857
  *Gpr151*                      G protein-coupled receptor 151                  54.78053147   0.360082493   85.45866943   0.576815937   -1.560018991        1
  *Gpr65*                        G-protein coupled receptor 65                  54.05701451   0.344145124   146.8162858   0.499301801   -2.715952538   0.158633441
  *Gpr182*                      G protein-coupled receptor 182                  53.23426477   0.326329103   85.11797113   0.57061356    -1.598932032   0.567583183
  *Gpr139*                      G protein-coupled receptor 139                  53.02682408   0.321891129   92.38956386   0.703743558   -1.742317506   0.258601234
  *Gpr21*                        G protein-coupled receptor 21                  52.0328213    0.300942497   72.73913052   0.354750161   -1.397947078   0.741406994
  *Gpr158*                      G protein-coupled receptor 158                  51.92947168   0.29879543    63.41336159   0.215644175   -1.221143977   0.637090301
  *Gpr63*                        G protein-coupled receptor 63                  50.9959338    0.279678293   97.86797672   0.803397981   -1.919132947   0.946152571
  *Gpr155*                      G protein-coupled receptor 155                  49.97110494   0.259290745   92.12694599   0.698933085   -1.843604341   0.324933584
  *Gpr176*                      G protein-coupled receptor 176                  48.96242303   0.239872194   53.89486012   0.107626211   -1.100739236   0.212932186
  *Gpr19*                        G protein-coupled receptor 19                  48.77902167   0.236413235   88.48209068   0.632092019   -1.813937378   0.478842035
  *Gpr116*                      G protein-coupled receptor 116                  47.64519495   0.215538201   95.65763979   0.763393274   -2.007708015   0.237971027
  *Gpr37*                        G protein-coupled receptor 37                  46.63567635   0.197714832   78.6480309    0.45484197    -1.686434873   0.33350725
  *Gpr12*                        G-protein coupled receptor 12                  43.87164829   0.152825917   89.07378877   0.642941053   -2.030326925   0.25456221
  *Gpr61*                        G protein-coupled receptor 61                  38.39824197   0.082156744   90.09705371   0.661711292   -2.346384863   0.725656569
  *Gpr137c*                     G protein-coupled receptor 137C                 38.28835404   0.080994315   89.45583486   0.649948364   -2.33637191        NA
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###### Expression of genes in the Adams family
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  ***Adams***                                                                                                                                                                   
  *Adam10*                    a disintegrin and metallopeptidase domain 10                **361.9310254**   **0.002605289**   **572.1144261**   **0.002197908**   -1.580727779   0.550173668
  *Adamtsl4*                                 ADAMTS-like 4                                  186.7402441       0.118746409       183.2381962       0.566007252     1.019111997    0.211012267
  *Adam17*                    a disintegrin and metallopeptidase domain 17                  179.240216        0.14151102        327.0666618       0.065754322     -1.824739275   0.43979387
  *Adam15*                    a disintegrin and metallopeptidase domain 15                   176.91194        0.149437176       236.3028883       0.258585267     -1.335709101   0.86373439
  *Adamts17*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 17     166.285723        0.191649211       155.1157197       0.83380408      1.072010776    0.17838096
  *Adam33*                    a disintegrin and metallopeptidase domain 33                  143.2533418       0.327655809       187.3018386       0.534022951     -1.307486696   0.607122322
  *Adamts10*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 10     135.1273739       0.394870436       188.5363387       0.524624481     -1.39524904    0.323396275
  *Adam1a*                    a disintegrin and metallopeptidase domain 1a                  125.7803888       0.487891176       142.3710583       0.982078417     -1.131901878   0.302441913
  *Adamtsl5*                                 ADAMTS-like 5                                  118.8409891       0.569188872       156.684171        0.816684342     -1.318435434   0.219403185
  *Adamts2*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 2      114.1361944       0.630738755       178.4675506       0.605650924     -1.563636772   0.981455083
  *Adamts1*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 1      109.4934689       0.696800634       288.2065321       0.117893987     -2.632180121   0.032615535
  *Adamts8*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 8      108.1270441       0.717269221       137.1852326       0.953251485     -1.268741171   0.670359886
  *Adamts7*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 7      104.7353254       0.770104259       126.3711396       0.811832594     -1.206576091   0.419966026
  *Adamts12*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 12     103.266259        0.793884786       253.7738818       0.198575014     -2.457471436   0.15311868
  *Adam4*                     a disintegrin and metallopeptidase domain 4                   101.4912963       0.823334302       103.9723183       0.506418509     -1.024445663   0.359728774
  *Adam11*                    a disintegrin and metallopeptidase domain 11                  96.48278062       0.910581493       93.32233476       0.367807843     1.033865911    0.16144701
  *Adam9*                     a disintegrin and metallopeptidase domain 9                   92.75365702       0.979347597       188.8591255       0.522191173     -2.036136705   0.321859941
  *Adamtsl2*                                 ADAMTS-like 2                                  90.38008471       0.975311941       104.9617327       0.519752615     -1.161336959   0.15311868
  *Adamtsl1*                                 ADAMTS-like 1                                  89.39194852       0.956099857       117.7630678       0.694883169     -1.317378911   0.689678828
  *Adam19*                    a disintegrin and metallopeptidase domain 19                  89.37741331       0.955815834       139.0754455       0.977089116     -1.556046884   0.632565024
  *Adamts16*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 16     89.1800757        0.951955786       99.78955189       0.450753967     -1.118966889   0.59922473
  *Adam22*                    a disintegrin and metallopeptidase domain 22                  88.31886637       0.935023936       180.7780221       0.586164894     -2.046878878   0.359894666
  *Adam8*                     a disintegrin and metallopeptidase domain 8                   86.51484226       0.899121169       92.0647805        0.35224885      -1.064150128   0.27105888
  *Adamts13*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 13     85.83956723       0.885539162       88.47392725       0.309067767     -1.030689344   0.478844207
  *Adamts9*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 9      83.27099934       0.833234446       189.3210225       0.518726499     -2.273552906   0.254563761
  *Adamts18*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 18     81.4196745        0.794981469       168.7064225       0.694045146     -2.072059653   0.162103461
  *Adamts14*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 14     80.27793265       0.771197631       82.77491987       0.244956077     -1.031104279   0.439155995
  *Adamts19*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 19     69.27461445       0.539213852       109.3590982       0.579553669     -1.578631639   0.390223674
  *Adamts4*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 4      68.27128822       0.518287473       74.72450982       0.165658834     -1.094523214   0.478842805
  *Adam21*                    a disintegrin and metallopeptidase domain 21                  60.66601728       0.36550739        64.64919733       0.088605328     -1.065657517   0.999197582
  *Adamts20*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 20     58.83741845       0.331040492       97.20251711       0.417043299     -1.652052719   0.478849238
  *Adam12*                    a disintegrin and metallopeptidase domain 12                  55.75657162       0.275742738       151.6194647       0.872877811     -2.719311111   0.196227734
  *Adamts5*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 5      55.55758605       0.272304468       141.9022559       0.987828457     -2.554147254   0.09184658
  *Adamts3*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 3      51.72989842       0.209742874       170.6776655       0.675392791     -3.299400748   0.478860496
  *Adamts15*     a disintegrin-like and metallopeptidase with thrombospondin type 1, 15     51.52479453       0.206595412       79.74566033       0.213438929     -1.547714281   0.219403185
  *Adamtsl3*                                 ADAMTS-like 3                                  47.33432389       0.147349513       66.40359283       0.10011701      -1.402863448   0.67686266
  *Adam23*                    a disintegrin and metallopeptidase domain 23                  43.57759051       0.103048326       117.4744258       0.69092512      -2.695753125   0.127323609
  *Adamts6*      a disintegrin-like and metallopeptidase with thrombospondin type 1, 6      40.47668384       0.073119037       142.2520509       0.983536216     -3.514419598   0.153396483

The ligands specific for ERBB2 are unknown, but ERBB2 can dimerize with EGFR. The heterodimers, similar to the EGFR homodimers, can be activated by amphiregulin (AREG), heparin-binding EGF-like growth factor (HB-EGF) and transforming growth factor α (TGFα) [@pone.0087038-Dhomen1]. Activation of the EGFR signaling is essential for embryonic eyelid closure [@pone.0087038-Miettinen1]. Based on the relative abundance of receptor gene expression, the EGFR/EGFR and EGFR/ERBB2 dimers are likely to form in the developing eyelid epithelium. Specifically, the EGFR/ERBB2 may be the dominant form in LE, whereas the EGFR/EGFR is likely to be the predominant form in IE cells.

ADAMS10 is important for the development of blood vessels and central nervous system, as well as in pathological conditions such as inflammation and cancer [@pone.0087038-Saftig1]. Recently, it was shown that ADAMS10 may be the sheddase of notch receptors, involved in the release of the extracellular domain and mediating skin development; however, its role in eyelid development has not been established. On the other hand, the *Adams17* knockout mice exhibit the open eye phenotype [@pone.0087038-Hassemer1]. ADAMS17 is the major sheddase of TGFα, amphiregulin, HB-EGF and epiregulin, and is essential for activation of EGFR during development [@pone.0087038-LeGall1], [@pone.0087038-Scheller1]. Of the *Lgr/Gpcr* families, only the *Lgr4 (−/−)* mice have defective keratinocyte motility and produce the EOB phenotype. The *Lgr4*, also known as *Gpr48*, was known to play a role in HB-EGF-induced EGFR activation [@pone.0087038-Kato1], [@pone.0087038-Wang1]. The expression of *Adams17* and *Lgr4* was both relatively abundant in the IE cells ([Tables 4](#pone-0087038-t004){ref-type="table"} and [5](#pone-0087038-t005){ref-type="table"}).

The most surprising observation made by the RNA array was that expression of EGFR ligands was scarce in the LE and IE cells ([Table 3](#pone-0087038-t003){ref-type="table"}). This was in clear contrast to previous findings made by *in situ* hybridization and immunohistochemistry, which showed that expression of TGFα and HB-EGF was up-regulated in a group cells located at the tip of the developing eyelid [@pone.0087038-Tao1], [@pone.0087038-Luetteke2], [@pone.0087038-Mann1]. The discrepancy could be explained if induction of ligand is a temporal-spatial event, taking place in a small number of cells and in a narrow window during embryogenesis. Hence, either ligand up-regulation was insignificant at E15.5, or the expression signals were masked or under-represented in the collectives of the LCM captured cells, exemplifying the limitations of this approach.

Taken together, the gene expression data confirm that many genetically identified "eyelid closure" factors, such as FGFR, EGFR, ADAMS17 and LGR4, are also relatively abundant in the LE and/or IE cells, but some highly expressed genes, including *Fgf9* and *Adam10*, are not known to be involved in eyelid closure. In comparison to the IE cells, the LE cells have higher expression of *Fgfr2* and *Erbb2*, which may contribute to differential signaling responses of these cells.

Expression of genes involved in the TGFβ signaling {#s3c}
--------------------------------------------------

The TGFβ superfamily consists of more than 30 structurally related ligands. They belong to the Bone Morphogenetic Proteins (BMPs), TGFβs and Activin/Inhibin subfamilies [@pone.0087038-Mueller1]. These ligands act selectively on seven type I and five type II receptors, resulting in receptor dimerization and activation. The receptors in turn activate two sets of so called R-SMAD. SMAD 1, 5, and 8 are substrates of Type I receptors for BMPs, whereas SMAD2 and 3 are substrates for Type I receptors for TGFβs and Activins. Once activated, R-SMADs assemble with SMAD4, also known as co-SMAD, and the heterodimer translocates into the nucleus to regulate responsive gene expression.

In LE and IE cells, the *Acvr2a* was the significantly expressed receptor gene, while *Smad2* was the abundantly expressed gene for intracellular transmitter. In addition, expression of *Bmp7* was relatively abundant in LE, and *Growth differentiation factor 10* (*Gdf10*) was abundant in IE cells ([Table 6](#pone-0087038-t006){ref-type="table"}). Furthermore, the IE cells had a slightly higher expression of *inhibin beta-B*, but much higher *Bmp5*, *Bmpr1a* and *Acvr1*.

10.1371/journal.pone.0087038.t006

###### Expression of genes in the TGFβ pathways
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  **The TGFβ family**                                                                                                                                                  
  ***Ligands***                                                                                                                                                        
  *Bmp7*                                  bone morphogenetic protein 7                     273.8032153       0.067190002     164.4743744   0.782003153   1.664716564    0.108606617
  *Inhbb*                                        inhibin beta-B                            189.8249605       0.267867653     229.6743744   0.349920499   -1.209927155   0.015593156
  *Bmp4*                                  bone morphogenetic protein 4                      187.94911        0.276418245     187.8661392   0.590049741   1.000441648    0.143749699
  *Gdf10*                               growth differentiation factor 10                   183.9074068       0.295778825     359.5450161   0.069068988   -1.95503282    0.661905204
  *Bmp2*                                  bone morphogenetic protein 2                     182.4613117       0.303028915     135.916909    0.921038359   1.342447478    0.212844348
  *Bmp1*                                  bone morphogenetic protein 1                     177.4112267       0.329755901     223.090068    0.380257649   -1.257474356   0.254597392
  *Tgfb2*                              transforming growth factor, beta 2                  172.6298162       0.35719415      300.8077524   0.142523738   -1.742501724   0.329864054
  *Bmp8a*                                bone morphogenetic protein 8a                     172.1103393       0.360306504     164.7585892   0.779391571   1.044621346    0.089033623
  *Gdf11*                               growth differentiation factor 11                   159.4675951       0.44467919      175.0468033   0.689538262   -1.097695135   0.201245908
  *Bmp3*                                  bone morphogenetic protein 3                     148.1166656       0.536120106     202.4442107   0.492685372   -1.366788875   0.477486266
  *Gdf7*                                growth differentiation factor 7                    147.8721307       0.538269393     153.7647042    0.8854851    -1.039849115   0.156938123
  *Inhba*                                        inhibin beta-A                            130.5738373       0.711324184     197.0395548   0.52691848    -1.509027833   0.712026446
  *Inha*                                         inhibin alpha                             130.1272773       0.716364388     204.5980265   0.479628814   -1.572291611   0.237387534
  *Bmp6*                                  bone morphogenetic protein 6                      125.274918       0.773059365     146.8885336   0.957046207   -1.172529473   0.286103958
  *Nodal*                                            nodal                                 103.8101562       0.934420257     85.88759992   0.315528911   1.208674551    0.247190059
  *Nog*                                              noggin                                100.0350956       0.876554259     83.19324041   0.286197111   1.202442592    0.195250499
  *Tgfb1*                              transforming growth factor, beta 1                  82.15218608       0.586613596     155.2142228   0.87090424    -1.889349879   0.210538535
  *Bmp8b*                                bone morphogenetic protein 8b                     81.76056963       0.580144573     102.4426736   0.511615715   -1.252959391   0.578881901
  *Inhbc*                                        inhibin beta-C                            74.08385854       0.454687654     82.33694939   0.277085231   -1.111402011   0.542313176
  *Inhbe*                                        inhibin beta E                            69.57742791       0.383541072     74.89766277   0.202836798   -1.076464955   0.479105423
  *Tgfb3*                              transforming growth factor, beta 3                  66.35517701       0.334591515     165.0505869   0.776715748   -2.487380704   0.254565854
  *Gdf9*                                growth differentiation factor 9                    64.46053434       0.306763225     71.94859953   0.176159291   -1.116165112   0.164059633
  *Gdf6*                                growth differentiation factor 6                    56.98847182       0.205865955     140.1852498   0.969536519   -2.459887856   0.274524202
  *Gdf3*                                growth differentiation factor 3                    55.99339008       0.193684893      108.15508    0.582739207   -1.931568705   0.511633304
  *Gdf5*                                growth differentiation factor 5                    51.66075472       0.14467988      60.11493281   0.087859418   -1.163647979   0.478845373
  *Bmp5*                                  bone morphogenetic protein 5                     51.55346944       0.143554136     314.8319068   0.11964688    -6.106900471   0.022920742
  *Gdf2*                                growth differentiation factor 2                    50.43190792       0.132051407     52.21430519   0.047202918   -1.03534265    0.201766807
  ***receptor***                                                                                                                                                       
  *Acvr2a*                                    activin receptor IIA                        **785.286694**   **0.006949311**   824.9994488   0.053983644   -1.050571027   0.535202305
  *Bmpr2*                          bone morphogenic protein receptor, type II              407.8628762       0.093450343     551.8506099   0.175491837   -1.353029761   0.371468892
  *Bmpr1a*                        bone morphogenetic protein receptor, type 1A             198.0829607       0.581647187     565.1672519   0.164924701   -2.853184594   0.028854135
  *Crim1*                         cysteine rich transmembrane BMP regulator 1               153.691022       0.876649887     204.0309462   0.951248863   -1.327539784   0.582802236
  *Tgfbr3*                       transforming growth factor, beta receptor III             143.0723153       0.965261747     200.257104    0.930110624   -1.399691503   0.323764976
  *Bambi*                      BMP and activin membrane-bound inhibitor, homolog           135.4573152       0.96669452      189.5920525   0.868484804   -1.399644251        1
  *Tgfbr1*                        transforming growth factor, beta receptor I              122.9008043       0.846582157     462.154534    0.27030705    -3.760386569   0.147558346
  *Acvrl1*                             activin A receptor, type II-like 1                  116.9128312       0.786093483     136.2815587   0.525171941   -1.165668107   0.633311024
  *Tgfbr2*                        transforming growth factor, beta receptor II             112.9823508       0.745389803     163.7414235   0.70827237    -1.449265503   0.319010671
  *Acvr1b*                                activin A receptor, type 1B                      101.4320918       0.622064638     110.4656142   0.350173625   -1.089059806   0.526331743
  *Acvr1*                                  activin A receptor, type 1                      100.3229914       0.609999096     247.9101709   0.82894344    -2.471120203   0.016173055
  *Acvr2b*                                    activin receptor IIB                          100.265421       0.609372034     111.8813641   0.359598279   -1.115851935   0.180539507
  *Bambi-ps1*                 BMP and activin membrane-bound inhibitor, pseudogene          80.5511445       0.393972944     80.94115829   0.168579167   -1.004841816   0.358188963
  *Bmpr1b*                        bone morphogenetic protein receptor, type 1B             76.22336452       0.347952441     116.7512861   0.392273989   -1.531699457   0.792545942
  *Tgfbrap1*             transforming growth factor, beta receptor associated protein 1    73.74312689       0.32209407      141.4743747   0.560446165   -1.918475398   0.475558452
  ***intracellular***                                                                                                                                                  
  *Smad2*                                  MAD homolog 2 (Drosophila)                      629.9527764       0.095677501     818.2805642   0.092838612   -1.298955406   0.195409967
  *Smad4*                                  MAD homolog 4 (Drosophila)                      354.4708292       0.364213634     447.8759579   0.391619063   -1.263505826   0.744635668
  *Smad3*                                  MAD homolog 3 (Drosophila)                      225.6921006       0.755336708     228.0715789   0.947457399   -1.010543029   0.158708217
  *Smad5*                                  MAD homolog 5 (Drosophila)                      219.8816039       0.781633462     368.1947529   0.555950137   -1.674513676   0.540729299
  *Smad1*                                  MAD homolog 1 (Drosophila)                      145.1756563       0.786661254     192.0409924   0.763436753   -1.322818145   0.39420827
  *Smad6*                                  MAD homolog 6 (Drosophila)                       110.418776       0.527526974     169.8452718   0.639157382   -1.538191944   0.835712394
  *Smad7*                                  MAD homolog 7 (Drosophila)                      96.23172938       0.41606715      127.125665    0.387073288   -1.321036895   0.180320764
  *Crim1*                                  MAD homolog 9 (Drosophila)                      59.54834067       0.147995136     84.36472138   0.154019199   -1.416743446   0.243731275

Previous genetic studies in mice have implicated TGF β signaling in eyelid closure. Huang *et. al*. carried out a methodical gene knockout study, in which each TGFβ cascade was specifically inactivated in ocular surface epithelium [@pone.0087038-Huang1]. The results showed that BMP, but not TGFβ or activin, signaling was required for eyelid closure. The EOB phenotype was observed in mice lacking the type I BMP receptor genes, *Acvr1* and *Bmpr1a*, the R-Smad genes, *Smad 1* and *Smad5*, and the Co-Smad gene, *Smad 4*, but not in mice lacking the type II TGFβ receptor gene *Tgfbr2* and the activin/TGFβ-activated R-Smad genes, *Smad2* and *Smad3*. Conditional deletion of *Bmpr1a* in the ectoderm and overexpression of the inhibitory SMAD7 in keratinocytes also led to an EOB phenotype [@pone.0087038-He1], [@pone.0087038-Andl1]. Our data showed that although the LE and IE cells had type II BMP receptor expression, only the IE cells expressed abundantly the type I receptor BMPR1A. Hence, activation of the BMP pathway can be carried out mainly in the IE cells.

Of the ligands highly expressed in IE cells, BMP5 is required for chondrocytic activity during endochondral ossification, and its deficiency leads to a number of skeletal defects [@pone.0087038-BailonPlaza1]. GDF10 is expressed in skeletal muscles but is dispensable for fetal development [@pone.0087038-Zhao1]. Recently, it was shown that GDF10, similar to TGFβ, can activate Smad2/3 and counteract the BMP signals [@pone.0087038-Matsumoto1]. Of the ligands highly expressed in LE cells, BMP7 is required for eye development, but is dispensable for eyelid closure [@pone.0087038-Dudley1]. The *inhibin βB* is required for embryonic eyelid closure; however, it may do so through a mechanism independent of SMAD [@pone.0087038-Huang1], [@pone.0087038-Zhang1], [@pone.0087038-Vassalli1]. These observations seem to support the idea that activation of the BMP pathways for eyelid closure is initiated by BMP4 produced by the the mesenchymal cells, but not ligands produced in the epithelial cells [@pone.0087038-Huang1]. Collectively, the gene expression pattern has identified differential expression of *Bmpr1a*, *Inhbb* and *Bmp5* in the LE and IE cells, and suggests that the BMP pathways may be preferentially activated in the IE cells.

Expression of genes involved in the canonical Wnt pathways {#s3d}
----------------------------------------------------------

The canonical Wnt pathway is activated by binding of ligands to the Frizzled (FZD) receptors, seven-transmembrane proteins with 10 family members (FZD 1--10), and co-receptors, such as the low-density lipoprotein-related receptor protein-5 or -6 (LRP5/6) [@pone.0087038-Bhanot1], [@pone.0087038-Wehrli1]. The receptor signal is transduced by the Dishevelled (DVL), which are scaffold proteins that interact with diverse proteins, including kinases, phosphatases and adaptor proteins. Intracellular transduction of the Wnt signal is carried out by stabilization and cytosolic accumulation of the critical mediator, β-catenin. The β-catenin then translocates to the nucleus, binds with members of the T-cell factor (TCF)/lymphocyte enhancer factor (Lef) family of transcription factors to regulate target gene expression [@pone.0087038-vande1].

Wnt ligands are a family of secreted signaling proteins, consisting of 19 members in mammals [@pone.0087038-Takada1]. Their activities are antagonized by the Secreted frizzled-related proteins (SFRPs) and the dickkopf homologs (DKKs). The SFRP is a family of secreted glycoproteins that may antagonize Wnt-mediated signaling by direct competitive interaction with Wnt ligands or by formation of non-signaling complexes with Frizzled proteins [@pone.0087038-Dann1], [@pone.0087038-Bafico1]. The DKKs, also secreted cysteine-rich proteins, interact with and inhibit the Wnt co-receptor Lrp5/6 [@pone.0087038-He2].

The array data showed that the *Fzd3* was the most abundant receptor and *Ctnnb1* and *Tcf4* were abundant intracellular transducers expressed in LE and IE cells. While *Sfrp2* was highly expressed in LE and IE cells, *Dkk2* and *Sfrp1* were abundantly expressed in the IE cells, and *Apcdd1* was abundant in the LE cells ([Table 7](#pone-0087038-t007){ref-type="table"}). In addition, *Dkk2* was 4-fold more abundant in the IE cells, conversely, *Apcdd1* was 1.7-fold more abundant in the LE cells.

10.1371/journal.pone.0087038.t007

###### Expression of genes in the Wnt pathways

![](pone.0087038.t007){#pone-0087038-t007-7}

                                                                      LE                                   IE               LE/IE                                                             
  ----------------------------------------- ------------------------------------------------------- ----------------- ----------------- ----------------- ----------------- ----------------- -----------------
  **Wnt**                                                                                                                                                                                     
  ***Ligands***                                                                                                                                                                               
  *Apcdd1*                                       adenomatosis polyposis coli down-regulated 1          483.5614722       0.053814884       277.7634161       0.800811376     **603.839414**    **0.011267485**
  *Sfrp2*                                             secreted frizzled-related protein 2            **348.8687731**   **0.020922218**   **654.0519384**   **0.037660546**     9263.508027       0.174835606
  *Sfrp4*                                             secreted frizzled-related protein 4              249.649771        0.112795852       316.9220374       0.273063678       914.2547726       0.40043203
  *Sfrp1*                                             secreted frizzled-related protein 1              211.7568665       0.218783911       573.2261883       0.057477828       3684.148697       0.273488221
  *Dkk1*                                              dickkopf homolog 1 (Xenopus laevis)              198.204605        0.277148921       180.9890829       0.736604814       269.0786174       0.391951411
  *Dkk2*                                              dickkopf homolog 2 (Xenopus laevis)              177.2474096       0.398062954     **721.2937998**   **0.027019747**   **6559.921251**     0.012726284
  *Wnt10a*                                        wingless related MMTV integration site 10a           176.4076412       0.403821253       184.4279311       0.717444422       245.8833545       0.478844672
  *Wnt2b*                                          wingless related MMTV integration site 2b           160.0394529       0.532467804       182.5437831       0.727876583       219.871688        0.926769779
  *Wnt5b*                                          wingless-related MMTV integration site 5B           142.8377647       0.70517094        175.1915846       0.770130122       185.4722475       0.479705404
  *Wnt10b*                                        wingless related MMTV integration site 10b           142.5633067       0.708262603       116.9518638       0.798107856       178.6266175       0.478844678
  *Wnt4*                                           wingless-related MMTV integration site 4            139.5806594       0.742557274       137.7167967        0.9727424        143.4919043       0.374613153
  *Wnt6*                                           wingless-related MMTV integration site 6            135.1613805       0.795715493       160.3732491       0.863152443       156.5903932       0.078390545
  *Wnt9b*                                           wingless-type MMTV integration site 9B             133.6151939       0.814972582       132.0830361       0.927644338       144.0370932       0.289503817
  *Dkk3*                                              dickkopf homolog 3 (Xenopus laevis)              110.7032791       0.86283769        136.6161576       0.964067385       114.8293998       0.206504995
  *Wnt7b*                                          wingless-related MMTV integration site 7B           109.9061131       0.850570159       103.0750617       0.669327096       164.2038904       0.135756387
  *Wnt3a*                                          wingless-related MMTV integration site 3A           105.5491979       0.782655232       115.4051747       0.784199907       134.5947595       0.279318999
  *Wnt9a*                                           wingless-type MMTV integration site 9A             103.910602        0.756793175       95.49126948       0.595623787        174.45677        0.259209416
  *Wnt2*                                           wingless-related MMTV integration site 2            91.74384223       0.562599042       83.13988271       0.472430417       194.1954603       0.625010844
  *Wnt8a*                                          wingless-related MMTV integration site 8A           87.51527434       0.495855788       84.11155152       0.48219671        181.4928897       0.68835004
  *Wnt7a*                                          wingless-related MMTV integration site 7A           84.77441059       0.453355276       82.50036825       0.466000878       181.9189931       0.203647077
  *Wnt11*                                          wingless-related MMTV integration site 11           84.42137039       0.447937944       103.3922602       0.672364507       125.5589334       0.30355669
  *Dkkl1*                                                       dickkopf-like 1                        80.6658968        0.391301917       49.5193887        0.155264947     **519.5370763**   **0.007020038**
  *Wnt5a*                                          wingless-related MMTV integration site 5A           77.85246206       0.350290283       212.9173909       0.57775569        134.7497973       0.113472971
  *Wnt3*                                           wingless-related MMTV integration site 3            70.09772231       0.245673781       64.97157496       0.292388531       239.7416961       0.080993879
  *Dkk4*                                              dickkopf homolog 4 (Xenopus laevis)              61.9542671        0.153300371       67.89828852       0.32063799        193.2218548       0.228653762
  *Wnt16*                                          wingless-related MMTV integration site 16         **47.68335129**   **0.046137884**     41.67678582       0.097927067       486.9271889       0.129518192
  ***Receptors***                                                                                                                                                                             
  *Fzd3*                                                frizzled homolog 3 (Drosophila)              **621.1053146**   **0.041393074**   **813.2745816**   **0.010731489**     57876.90198       0.478857045
  *Fzd9*                                                frizzled homolog 9 (Drosophila)                421.0632821       0.122596071       392.1751139       0.199012898       2115.758764       0.87130258
  *Dvl3*                                            dishevelled 3, dsh homolog (Drosophila)            413.3018893       0.128448795       402.3131688       0.183945914       2246.866375       0.154874206
  *Lrp6*                                      low density lipoprotein receptor-related protein 6       361.5150568       0.177156701       431.6042255       0.146840648       2461.954923       0.583273548
  *Lrpap1*                                   low density lipoprotein receptor-related protein AP-1     251.7744179       0.374371039       394.0853272       0.196076999       1284.058914       0.305691833
  *Fzd6*                                                frizzled homolog 6 (Drosophila)                228.5769945       0.444226001       253.913148        0.59664302        383.105118        0.809625026
  *Lrp1*                                      low density lipoprotein receptor-related protein 1       203.9297815       0.535517337       263.3174719       0.553577155       368.3854721       0.263717473
  *Daam1*                                     dishevelled associated activator of morphogenesis 1      180.844634        0.640904694       283.032779        0.472862601       382.4464733       0.627127554
  *Fzd7*                                                frizzled homolog 7 (Drosophila)                160.7760067       0.751649955       186.5780299       0.995186416       161.5536588       0.434764207
  *Lrp4*                                      low density lipoprotein receptor-related protein 4       150.3594548       0.817266008       180.2743744       0.947588434       158.6759076       0.546664989
  *Lrp12*                                         low density lipoprotein-related protein 12           149.1675011       0.825158313       308.3467702       0.386144171       386.3000201       0.392040335
  *Fzd10*                                              frizzled homolog 10 (Drosophila)                143.5471885       0.863477711        146.15934        0.667091155       215.1837683       0.093092703
  *Fzd5*                                                frizzled homolog 5 (Drosophila)                133.4039545       0.937417185       179.4493072       0.941246041       141.731225        0.268788395
  *Lrp8*                                      low density lipoprotein receptor-related protein 8       129.9627772       0.963950394       173.179921        0.892234598       145.6598718       0.96540813
  *Daam2*                                     dishevelled associated activator of morphogenesis 2      129.5253696       0.96737678        213.5127234       0.819485923       158.0568573       0.232134795
  *Lrp5*                                      low density lipoprotein receptor-related protein 5       124.4582986       0.992036878       182.9363107       0.967875244       128.5891952       0.478848283
  *Fzd1*                                                frizzled homolog 1 (Drosophila)                119.3852371       0.949735838       114.1795981       0.390301586       305.8794564       0.212940516
  *Dvl2*                                            dishevelled 2, dsh homolog (Drosophila)            113.9854854       0.902859622       168.4318283       0.854195591       133.4419032       0.473187759
  *Fzd2*                                                frizzled homolog 2 (Drosophila)                112.3533043       0.888313733       109.4746106       0.351250408       319.8666868       0.159410823
  *Lrp3*                                      low density lipoprotein receptor-related protein 3       108.3015606       0.851451757       147.8738335       0.681889718       158.8256248       0.897879402
  *Dvl1*                                            dishevelled, dsh homolog 1 (Drosophila)            107.1117074       0.84042385        145.3054246       0.659703892     **162.3633097**   **0.026996352**
  *Lrp10*                                     low-density lipoprotein receptor-related protein 10      60.98575657       0.357857719       117.050989        0.414542002       147.1159889       0.47884479
  *Fzd8*                                                frizzled homolog 8 (Drosophila)                55.12069055       0.294466513       85.06205341       0.170546176       323.2009761       0.478843194
  *Frzb*                                                   frizzled-related protein                    52.66725106       0.26854277        167.7802652       0.848916887       62.04052699       0.356862886
  *Lrp11*                                     low density lipoprotein receptor-related protein 11      44.59142388       0.18728742        85.39483827       0.172671979       258.2435451       0.202392746
  *Lrp2*                                      low density lipoprotein receptor-related protein 2       40.27024362       0.147448705       95.17067762       0.239837412       167.9064298       0.254562864
  *Fzd4*                                                frizzled homolog 4 (Drosophila)                31.47827903       0.07796015        128.7726731       0.515600438       61.05169179       0.187858824
  *Lrp2bp*                                                   Lrp2 binding protein                    **26.76371598**   **0.04889444**      70.3777375        0.089199837       300.0422086       0.93675131
  ***Intracellular destruction complex***                                                                                                                                                     
  *Ctnnb1*                                       catenin (cadherin associated protein), beta 1         1048.175521       0.190192411       1125.036148       0.143218133       7318.734695       0.207958814
  *Gsk3b*                                               glycogen synthase kinase 3 beta                676.0486341       0.434376095       825.1731378       0.278543966       2427.080521       0.920205733
  *Apc*                                                   adenomatosis polyposis coli                  254.3465152       0.692184095       482.4879277       0.670699658       379.2256522       0.150092586
  *Gsk3a*                                              glycogen synthase kinase 3 alpha                765.6427453       0.351520757       402.5362199       0.839207813       912.3398685       0.085845708
  *Axin2*                                                            axin2                             223.7622736       0.582166117       202.2410415       0.521127278       429.3812343       0.249343351
  *Axin1*                                                           axin 1                             164.4811794       0.357051665       192.2826903       0.48170679        341.4549736       0.332440932
  *Apc2*                                                 adenomatosis polyposis coli 2                 98.85499999       0.124948223       94.26789929       0.114534278       863.1040594       0.101742905
  ***Nuclear Factors***                                                                                                                                                                       
  *Tcf4*                                                    transcription factor 4                     986.4723963       0.251483716       1197.491493       0.248273344       3973.331888       0.889945086
  *Tcf3*                                                    transcription factor 3                     190.5045881       0.48987916        179.8919114       0.57458275        331.552919        0.312585321
  *Lef1*                                              lymphoid enhancer binding factor 1               234.9432668       0.648208795       173.6581248       0.553021659       424.8355608       0.207245367

Among the receptors highly expressed, FZD9 is required for bone morphogenesis and is a receptor for non-canonical Wnt that activates JNK, while DVL3 is required for cardiac outflow tract development [@pone.0087038-Ranheim1]--[@pone.0087038-Etheridge1]. Neither, however, is known to be involved in eyelid closure. Conversely, FZD3, involved in axonal outgrowth, and FZD6, required for hair patterning, can collaborate on eyelid closure. Knocking out both *Fzd3* and *Fzd6* causes "unfused eyelids" in 10% of the offsprings [@pone.0087038-Wang2], [@pone.0087038-Guo1]. Likewise, the *Lrp6(−/−)* mice display multiple defects, including open eyes [@pone.0087038-Kato2]--[@pone.0087038-Zhou2]. Although the nuclear factor TCF4 has not been implicated in eyelid closure, TCF3, through interactions with β-catenin, is shown to be crucial for eyelid closure [@pone.0087038-Wu1], [@pone.0087038-Korinek1].

Using the Wnt reporter mice, it was shown that Wnt activity is repressed overall in eyelid epithelium [@pone.0087038-Wu1]. The repression is likely to be mediated by the expression of Wnt antagonists. On the one hand, the retinoic acid (RA)-Pitx2 pathway can induce the expression of Wnt antagonists in the periocular mesenchyme; while on the other hand, the BMP and FGFR2 pathways can activate the expression of Wnt antagonists in ocular surface epithelium [@pone.0087038-Huang1], [@pone.0087038-Kumar1]. Our results showed that antagonists could indeed be produced in the LE and IE cells. Of the antagonists, SFRP4 is dispensable for fetal development; SFRP1 and SFRP2 have redundant functions in regulating embryonic patterning, and DKK2 is required for epithelial differentiation and eyelid closure [@pone.0087038-Gage1], [@pone.0087038-Satoh1]--[@pone.0087038-Mukhopadhyay1]. In addition, APCDD1 is a membrane-bound glycoprotein that can interact with WNT3A and LRP5 and inhibit Wnt signaling in a cell-autonomous manner [@pone.0087038-Shimomura1]. Our data also suggested that the LE and IE cells might use distinct antagonists for Wnt inhibition.

In the Wnt reporter mice, it is also shown that the canonical Wnt pathway is activated in restricted areas of the developing eyelids [@pone.0087038-Wu1]. Specifically, Wnt activity is induced in a small group of epithelial cells positioned at the transition zone between the palpebral conjunctiva and eyelid tip epidermis, so called mucocutaneous junction (MCJ) [@pone.0087038-Knop1], [@pone.0087038-Riau1]. Repression of Wnt in the MCJ cells results in failure of eyelid closure [@pone.0087038-Wu1]. Hence, Wnt may establish distinct morphogenetic fields within the developing eyelids, so that activation takes place in MCJ, but repression occurs elsewhere. Isolation of the MCJ cells and characterizing their molecular signatures may help to understand the developmental roles of the temporal-spatial Wnt activity.

Genes in the SHH, NOTCH and the PCP pathways {#s3e}
--------------------------------------------

The Sonic Hedgehog ligands bind to the transmembrane receptor Patched (*Ptch*) to initiate pathway signaling [@pone.0087038-Rubin1]. In its inactive state, PTCH exerts an inhibitory effect on the signal transducer Smoothened (SMO), but upon ligand binding, the inhibition on SMO is released and downstream signaling occurs. This leads to the activation of the Gli transcription factors. We found that expression of *Ptch1*, *Smo* and *Gli2*, but not the ligand genes, was relatively abundant in IE and LE cells ([Table 8](#pone-0087038-t008){ref-type="table"}). This is in agreement with the idea that activation of Shh pathway is dependent on *Ptch1* expression induced by the FGFR signaling in the eyelid epithelial cells, and the SHH expression induced by FGF10 in the periocular mesenchyme [@pone.0087038-Tao1], [@pone.0087038-Huang1]. Furthermore, many of the genes were expressed slightly but significantly higher in LE than in IE cells, suggesting that this pathway may be differentially activated in these cells.

10.1371/journal.pone.0087038.t008

###### Expression of genes in the Shh pathways
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                                        LE                      IE           LE/IE                                                   
  ---------------------- --------------------------------- ------------- ------------- ------------- ------------- ----------------- -----------------
  **The SHH pathways**                                                                                                               
  ***Ligands***                                                                                                                      
  *Ihh*                           Indian hedgehog           147.1238905   0.343655971   163.4318248   0.257104942     -1.11084491       0.159752369
  *Shh*                           sonic hedgehog            114.5198084   0.921343416   90.82711316   0.707793588     1.260854875       0.057945482
  *Dhh*                           desert hedgehog           81.67346381   0.295695919   78.22022394   0.448188021     1.04414766        0.356208622
  **Receptors**                                                                                                                      
  *Ptch1*                        patched homolog 1          732.1286053   0.151756837   387.1397413   0.159961283     1.891122319       0.065360857
  *Smo*                   smoothened homolog (Drosophila)   232.128924    0.720827257   236.9900927   0.535847474    -1.020941676       0.043881503
  *Ptch2*                        patched homolog 2          177.2644254   0.916565611   129.2130979   0.724494389    **1.3718766**    **0.046898841**
  *Ptchd2*                  patched domain containing 2     62.24859935   0.381277507   81.98061543   0.279593571     -1.31698731       0.215221343
  *Ptchd1*                  patched domain containing 1     53.35715576   0.307765053   111.3612941   0.554778418    -2.087092023       0.350146107
  **Nuclear factors**                                                                                                                
  *Gli2*                  GLI-Kruppel family member GLI2    323.275679    0.284969075   208.0211403   0.899972309   **1.554052047**   **0.014527635**
  *Gli1*                  GLI-Kruppel family member GLI1    254.0822594   0.875224653   194.1079797   0.351745286     1.308973798       0.095148044
  *Gli3*                  GLI-Kruppel family member GLI3    219.0576273   0.361664682   230.2743744   0.290554641     -1.05120455       0.513564801

The NOTCH cascade consists of NOTCH, its ligands, and intracellular signal transmitters. Mammals possess four different notch receptors, including NOTCH 1--4, which are membrane-tethered transcription factors. They are activated by the ligands of the Delta, Serrate, Lag-2 families. In LE and IE cells, expression of NOTCH ligands and receptors was overall low, but *Jag1* was 1.5-fold and *Notch 1* was 1.5-fold more abundant in the LE than in the IE cells ([Table 9](#pone-0087038-t009){ref-type="table"}). The role of NOTCH in eyelid development however has been inconclusive. On the one hand, constitutive activation of NOTCH in periocular mesenchyme leads to abnormalities in cranial facial development and incomplete eyelid closure; on the other hand, genetic ablation of NOTCH signaling in ocular surface epithelium does not cause an EOB phenotype [@pone.0087038-Gage1], [@pone.0087038-Huang1], [@pone.0087038-Zhang2]--[@pone.0087038-Zhang3].

10.1371/journal.pone.0087038.t009

###### Expresison of genes in the Notch pathways
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  **The Notch pathway**                                                                                                                 
  **Ligands**                                                                                                                           
  *Jag1*                               jagged 1                291.2881266   0.105374112   197.9402992   0.311677556     1.471595869       0.091068921
  *Dlk2*                   delta-like 2 homolog (Drosophila)   197.9473027   0.274112696   249.333394    0.127067789    -1.259594804       0.478878354
  *Dlk1*                   delta-like 1 homolog (Drosophila)   160.8057089   0.417447523   228.2743744   0.183766506    -1.419566358       0.713116482
  *Jag2*                               jagged 2                123.4294683   0.652072473   136.4169347   0.855040508    -1.105221764       0.044310212
  *Cntn2*                             contactin 2              90.82785012   0.973262036   135.9033179   0.861637408     -1.49627364       0.478848975
  *Dll3*                       delta-like 3 (Drosophila)       82.77031667   0.925984883   94.41873989   0.524248856    -1.140731891       0.145970717
  *Dll1*                       delta-like 1 (Drosophila)        58.175215    0.566824074   86.88336375   0.411054244    -1.493477312       0.478850038
  *Dll4*                       delta-like 4 (Drosophila)       50.38482269   0.44226217    74.30942025   0.241923917    -1.474837387            1
  *Cntn1*                             contactin 1              39.8413045    0.276648487   96.92132086   0.562892733    -2.432684423       0.478853114
  *Cntn3*                             contactin 3              29.72792312   0.137186651   79.6325516    0.309575696    -2.678712242       0.072194119
  **Receptor**                                                                                                                          
  *Notch1*                 Notch gene homolog 1 (Drosophila)   270.8341937   0.165136399   174.4555076   0.868921425   **1.552454247**   **0.049764805**
  *Notch3*                 Notch gene homolog 3 (Drosophila)   170.0357029   0.942106713   161.7710801   0.837205225     1.051088382       0.134639977
  *Notch2*                 Notch gene homolog 2 (Drosophila)   129.2094217   0.481897644   216.7538874   0.218496242    -1.677539335       0.202460017
  *Notch4*                 Notch gene homolog 4 (Drosophila)   126.7584274   0.44882783    132.3657333   0.23400882     -1.044236158       0.478848306

The non-canonical Wnt/planar cell polarity (PCP) pathway regulates cell orientation within the plane of a cell sheet and is involved in convergent extension during development [@pone.0087038-Murdoch1], [@pone.0087038-Wang3]. WNT5A, WNT5B, and WNT11 are the non-canonical WNT ligands, and FZD 3/6 and DVL are the receptors, which transmit signals through the core PCP proteins. The core is composed of cytoplasmic Prickled (PK), the transmembrane protein Van Gogh, the cadherin Starry/Flamingo (STAN/FMI), and the Ankyrin repeat protein Diego (DGO) [@pone.0087038-Adler1], [@pone.0087038-Seifert1]. In addition, SEC24B is a cargo-binding component of the COPII vesicle coat [@pone.0087038-Miller1]. The COPII vesicles are the primary pathway for active transport of secretary proteins from the ER to the Golgi. Though SEC24B is not a PCP core component, it selectively sorts VANGL2 into COPII vesicles thereby controlling PCP assembly and activity.

Expression of non-canonical Wnt ligands and core receptors was overall low in LE and IE cells with a few exceptions ([Table 10](#pone-0087038-t010){ref-type="table"}). While expression of *Fzd3* and *Dvl3* was relatively abundant in LE and IE cells, expression of *naked cuticle 1 homolog* (*Nkd1*) was higher in LE, and expression of *Sec24b* was higher in IE cells. Genetic inactivation of many PCP genes, including *Fzd3/6*, *Dvl2*, *Vangl2*, *Scrb1*, *Ptk7* and *Celsr1*, as well as *Sec24b*, causes craniofacial developmental abnormalities, including open eyelids [@pone.0087038-Kibar1]--[@pone.0087038-Harris3], [@pone.0087038-Torban1], [@pone.0087038-Merte1]. It is yet to be determined whether the eyelid defect is secondary to craniofacial abnormalities resulting from inactivation of the PCP pathways.

10.1371/journal.pone.0087038.t010

###### Expression of genes in the PCP pathways

![](pone.0087038.t010){#pone-0087038-t010-10}

                                                        LE                                IE               LE/IE                                                            
  ------------------------------ ------------------------------------------------- ----------------- ----------------- ----------------- ---------------- ----------------- -----------------
  ***Ligands***                                                                                                                                                             
  *Wnt5b*                            wingless-related MMTV integration site 5B        142.8377647       0.251818298       175.1915846      0.766909218      -1.226507465       0.479705404
  *Wnt11*                            wingless-related MMTV integration site 11        84.42137039       0.652672424       103.3922602       0.26497932      -1.224716677       0.30355669
  *Wnt5a*                            wingless-related MMTV integration site 5A        77.85246206       0.486496883       212.9173909       0.41319785      -2.734883204       0.113472971
  ***Receptors/co-receptors***                                                                                                                                              
  *Fzd3*                                  frizzled homolog 3 (Drosophila)             621.1053146       0.147519425       813.2745816       0.09579658      -1.309398845       0.478857045
  *Fzd6*                                  frizzled homolog 6 (Drosophila)             228.5769945       0.707784383       253.913148       0.843771153      -1.110842972       0.809625026
  *Ptk7*                                  PTK7 protein tyrosine kinase 7              131.0165691       0.823649378       130.2743778      0.519053347       1.005697139       0.271910987
  *Ror2*                          receptor tyrosine kinase-like orphan receptor 2     117.9563668       0.737154026       147.612897       0.626132679      -1.251419496       0.347033389
  *Ror1*                          receptor tyrosine kinase-like orphan receptor 1     49.65911375       0.205977337       121.7021912      0.464979521      -2.450752379       0.254560774
  ***PCP core molecules***                                                                                                                                                  
  *Nkd1*                               naked cuticle 1 homolog (Drosophila)         **497.1448806**   **0.019711524**     296.7290136      0.106660925       1.675417158       0.059347345
  *Dvl3*                              dishevelled 3, dsh homolog (Drosophila)       **413.3018893**   **0.042567398**   **402.3131688**   **0.02480151**     1.027313847       0.154874206
  *Nkd2*                               naked cuticle 2 homolog (Drosophila)           190.6089541       0.450452887       228.3393772      0.284509583       -1.19794675       0.254709977
  *Celsr1*                        cadherin, EGF LAG seven-pass G-type receptor 1      143.6045951       0.772719535       135.8743755      0.995259555       1.056892402       0.06910682
  *Scrib*                                 scribbled homolog (Drosophila)              141.4973543       0.791394792       147.7381109      0.866894575      -1.044105111       0.121047968
  *Vangl1*                              vang-like 1 (van gogh, Drosophila)            131.9203286       0.88139334        183.465837       0.537481643      -1.390732111       0.345788803
  *Dvl2*                              dishevelled 2, dsh homolog (Drosophila)         113.9854854       0.927335626       168.4318283      0.660389528      -1.477660316       0.473187759
  *Celsr2*                        cadherin, EGF LAG seven-pass G-type receptor 2      112.3460222       0.908420016       106.673064       0.611755773       1.053180794       0.021674089
  *Dvl1*                              dishevelled, dsh homolog 1 (Drosophila)         107.1117074       0.846548722       145.3054246      0.894048687     **-1.35657836**   **0.026996352**
  *Ankrd6*                                    ankyrin repeat domain 6                 90.63533762       0.639562999       97.05578363      0.481777055       -1.07083822       0.479084068
  *Prickle3*                              prickle homolog 3 (Drosophila)              84.83043606       0.563803071       79.27375338      0.261432352       1.07009486        0.177745976
  *Prickle4*                              prickle homolog 4 (Drosophila)              80.8529364        0.511691571       106.7370389      0.612627926      -1.320138064       0.286671885
  *Celsr3*                        cadherin, EGF LAG seven-pass G-type receptor 3      79.55497285       0.494713944       86.50478832      0.346172204      -1.087358656       0.355310588
  *Vangl2*                              vang-like 2 (van gogh, Drosophila)            75.68020564       0.444286165       94.43627767      0.447152767      -1.247833259       0.215185176
  *Prickle2*                              prickle homolog 2 (Drosophila)              65.94364237       0.321422465       109.7444823      0.653633857      -1.664216266            1
  *Prickle1*                              prickle homolog 1 (Drosophila)              55.46965977       0.201923392       73.22103016      0.197860129      -1.320019457       0.912533584
  ***COPII vesicle***                                                                                                                                                       
  *Sec24b*                              Sec24 related gene family, member B           365.8694535       0.189701062     **499.6743376**   **0.03653965**    -1.365717561       0.217269914
  *Sec24c*                              Sec24 related gene family, member C           334.7646094       0.254211948       299.8711063      0.603744187       1.116361671       0.170013082
  *Sec24a*                              Sec24 related gene family, member A           259.536154        0.51602466        329.3725376      0.968581141      -1.269081523       0.67083081
  *Sec23ip*                                  Sec23 interacting protein                 138.61087        0.575686004       308.2026826      0.704727443      -2.223510194       0.218337641
  *Sec23b*                                    SEC23B (S. cerevisiae)                  128.5699587       0.481018944       308.1660899      0.704276804      -2.396874767       0.326855537
  *Sec24d*                              Sec24 related gene family, member D           126.0420706       0.457514143       272.5389393      0.313682332      -2.162285481       0.165560621
  *Sec23a*                                    SEC23A (S. cerevisiae)                  105.0683677       0.274034086       347.439549       0.815321433       -3.30679496       0.243266726

Validation of differential gene expression by qRT-PCR {#s3f}
-----------------------------------------------------

Collectively, the microarray studies identified 20 genes of the morphogenetic signaling pathways were differentially expressed in the LE and IE cells ([Fig. 1](#pone-0087038-g001){ref-type="fig"}). To validate the results, we used qRT-PCR to examine 7 relatively abundant genes ([Fig. 2A and 2B](#pone-0087038-g002){ref-type="fig"}). Consistent with the array data, qRT-PCR showed that the LE cells had significantly more expression of *Erbb2*, *Gli2* and *Notch1*, but significantly less expression of *Adamts1*, *Bmpr1a* and *Dkk2* than the IE cells. Also consistent with the array data, qRT-PCR showed that the LE cells had a slight but insignificant decrease in expression of *Tcf4* and *Adam17* than the IE cells ([Fig. 2C](#pone-0087038-g002){ref-type="fig"}, [Tables 4](#pone-0087038-t004){ref-type="table"} and [7](#pone-0087038-t007){ref-type="table"}). Different from the array data, however, qRT-PCR detected no difference of *Fgfr2* expression in LE and IE cells ([Fig. 2A](#pone-0087038-g002){ref-type="fig"}). Hence, most gene expression pattern observed by cDNA array can be validated by qRT-PCR.

![Summary of the microarray analyses.\
Genes differentially expressed in LE and IE cells. Statistical significant differential gene expression between LE and IE samples were summarized in (A) genes expressed more in LE than IE cells, and (B) genes expressed less in LE than IE cells. *\* p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001* are considered significant.](pone.0087038.g001){#pone-0087038-g001}

![Differential gene expression in LE and IE cells.\
Total RNA isolated from LE and IE cells of fetuses at E15.5 was used for qRT-PCR for the expression of (A) *Fgfr2*, *Errb2*, *Gli2* and *Notch1*, (B) *Adamts1*, *Bmpr1a* and *Dkk2* and (C) *Tcf4* and *Adam17*. Relative expression was calculated based on that of *Gapdh* in each sample, and compared to the expression in IE cells, set as 1. The results are shown as mean ± SD from at least 3 samples and triplicate PCR of each sample. Statistic analyses were done by Student t-test, *\*\*\*p\<0.001* is considered significant. (D) Figure depicting the LE and IE cells in the developing eyelid and expresison of signaling factors.](pone.0087038.g002){#pone-0087038-g002}

Conclusions {#s4}
===========

The LE and IE cells have the same ontogenic origin, but different developmental fate. The fate divergence can be detected at E15.5, as the IE cells develop gene expression signatures towards the muscle lineage, while the LE cells express epidermal markers. The LE cells also undergo morphological changes and migrate at E15.5 to eventually form the closed eyelid. This morphogenetic event is thought to be dictated by specific activation of signaling pathways. Our results show that the LE and IE cells are overall quite similar in the compositions for the major "eyelid closure pathways", but there are a few differences ([Fig. 2D](#pone-0087038-g002){ref-type="fig"}). The LE cells have a slight but significant increased expression of *Erbb2* of the EGF pathway, *Pach1*and *2* and *Gli2* of the Shh pathway, *Jag1* and *Notch 1* of the Notch pathway, and *Nkd1* of the PCP pathway, but the IE cells have higher expression of *Bmpr1a*, *Acvr1* and *Bmp5* of the BMP pathway. In addition, we find higher expression of *Apcdd1* in the LE cells, but higher expression of *Dkk2* in the IE cells of the Wnt pathway. Differential expression of signaling molecules in the eyelid epithelium may be one of the mechanisms for ectopic activation of morphogenetic pathways. The contributions of the eyelid mesenchyme should also be crucial and can be evaluated using the similar approach. Combination of LCM, cDNA array and pathway analyses can serve as a preliminary screening tool for identifying critical developmental genes for further expression and knockout studie.
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